2-aminoadipic acid has been researched along with trolamine salicylate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JF; Cronstein, BN; Delano, D; Desai, A; Fink, JS; Jacobson, MA; Montesinos, MC | 1 |
1 other study(ies) available for 2-aminoadipic acid and trolamine salicylate
| Article | Year |
|---|---|
Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68.
Topics: 2-Aminoadipic Acid; Acute Disease; Animals; Antirheumatic Agents; Arthritis; Methotrexate; Mice; Mice, Knockout; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Tumor Necrosis Factor-alpha | 2003 |